{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:13:33Z","timestamp":1789794813978,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209271","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T21:41:35Z","timestamp":1703108495000},"page":"209271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare"],"prefix":"10.1016","volume":"157","author":[{"given":"Jason B.","family":"Gibbons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Zivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach Y.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.josat.2023.209271_bb0005","first-page":"792","article-title":"Perception of racism explains the difference between Blacks\u2019 and Whites\u2019 level of healthcare trust","volume":"16","author":"Adegbembo","year":"2006","journal-title":"Ethnicity & Disease Journal"},{"issue":"2","key":"10.1016\/j.josat.2023.209271_bb0010","article-title":"Trends in black and white opioid mortality in the United States, 1979-2015","volume":"30","author":"Alexander","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.josat.2023.209271_bb0015","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder","volume":"388","author":"Barnett","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2023.209271_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108661","article-title":"Quantifying opioid use disorder cascade of care outcomes in an American Indian tribal nation in Minnesota","volume":"222","author":"Boyd","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209271_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13722-019-0149-1","article-title":"Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco","volume":"14","author":"Carter","year":"2019","journal-title":"Addiction Science and Clinical Practice"},{"key":"10.1016\/j.josat.2023.209271_bb0030","author":"Center for Medicare and Medicaid Services Office of Minority Health"},{"key":"10.1016\/j.josat.2023.209271_bb0035","author":"Congressional Budget Office"},{"issue":"8","key":"10.1016\/j.josat.2023.209271_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.3250","article-title":"Mandated implicit Bias training for health professionals\u2014A step toward equity in health care","volume":"3","author":"Cooper","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"2","key":"10.1016\/j.josat.2023.209271_bb0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamapsychiatry.2013.3575","article-title":"Race\/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States","volume":"71","author":"Cummings","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.josat.2023.209271_bb0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2215-0366(23)00119-0","article-title":"Increasing overdose deaths among black Americans: A review of the literature","volume":"10","author":"Gibbons","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.josat.2023.209271_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2022.100026","article-title":"Group-based medical mistrust and care expectations among black patients seeking addiction treatment","volume":"2","author":"Hall","year":"2022","journal-title":"Drug and Alcohol Dependence Reports"},{"key":"10.1016\/j.josat.2023.209271_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108551","article-title":"Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment","volume":"133","author":"Hall","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209271_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in new York City","volume":"40","author":"Hansen","year":"2013","journal-title":"Journal of Behavioral Health Services Research"},{"key":"10.1016\/j.josat.2023.209271_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108927","article-title":"Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use","volume":"227","author":"Hollander","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209271_bb0075","author":"Kaiser Family Foundation"},{"issue":"5","key":"10.1016\/j.josat.2023.209271_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5852","article-title":"Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients","volume":"3","author":"Kilaru","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209271_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00380237.2009.10571347","article-title":"Racial and ethnic composition as a correlate of medication availability within addiction treatment organizations","volume":"42","author":"Knudsen","year":"2009","journal-title":"Sociological Focus"},{"key":"10.1016\/j.josat.2023.209271_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209271_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108512","article-title":"Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample","volume":"220","author":"Krawczyk","year":"2021","journal-title":"Drug and Alcohol Dependence."},{"issue":"9","key":"10.1016\/j.josat.2023.209271_bb0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2023.209271_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","article-title":"Racial\/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged \u226518 years in metropolitan areas - United States, 2015-2017","volume":"68","author":"Lippold","year":"2019","journal-title":"The Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2023.209271_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","article-title":"Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration","volume":"160","author":"Manhapra","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209271_bb0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2105\/AJPH.2019.305368","article-title":"The geographic distribution of fentanyl-involved overdose deaths in Cook County, Illinois","volume":"110","author":"Nesoff","year":"2020","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209271_bb0120","series-title":"Medicare fee-for-service beneficiaries with opioid use disorder in 2018: Disparities in prevalence by beneficiary characteristics","author":"Niles","year":"2020"},{"issue":"2","key":"10.1016\/j.josat.2023.209271_bb0125","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/1475-6773.12712","article-title":"Log odds and the interpretation of logit models","volume":"53","author":"Norton","year":"2018","journal-title":"Health Services Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209271_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.2018.6971","article-title":"Odds ratios\u2014Current best practice and use","volume":"320","author":"Norton","year":"2018","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.josat.2023.209271_bb0135","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jama.2019.1954","article-title":"Marginal effects\u2014Quantifying the effect of changes in risk factors in logistic regression models","volume":"321","author":"Norton","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.josat.2023.209271_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232086","article-title":"Retention of patients in opioid substitution treatment: A systematic review","volume":"15","author":"O\u2019Connor","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2023.209271_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2019.03.009","article-title":"Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program","volume":"200","author":"Payne","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209271_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228755","article-title":"Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings","volume":"15","author":"Pro","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2023.209271_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108588","article-title":"Race, ethnicity, and emergency department post-overdose care","volume":"131","author":"Reddy","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209271_bb0160","series-title":"Stratified measures: How HEDIS can enhance health equity","article-title":"October","author":"Reynold","year":"2022"},{"key":"10.1016\/j.josat.2023.209271_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209271_bb0170","first-page":"19","article-title":"Racial disparities in payment source of opioid use disorder treatment among non-incarcerated justice-involved adults in the United States","volume":"23","author":"Sanmartin","year":"2020","journal-title":"The Journal of Mental Health Policy and Economics"},{"key":"10.1016\/j.josat.2023.209271_bb0175","author":"Substance Abuse and the Mental Health Services Administration"},{"issue":"1","key":"10.1016\/j.josat.2023.209271_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1172\/JCI134708","article-title":"Medications for opioid use disorders: Clinical and pharmacological considerations","volume":"130","author":"Volkow","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.josat.2023.209271_bb0185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2105\/AJPH.2019.305525","article-title":"Retention of patients with multiple vulnerabilities in a federally qualified health center buprenorphine program: Pennsylvania, 2017-2018","volume":"110","author":"Weinstein","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.josat.2023.209271_bb0190","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s40615-021-01007-6","article-title":"Fentanyl, heroin, and cocaine overdose fatalities are shifting to the black community: An analysis of the state of Connecticut","volume":"9","author":"Wu","year":"2020","journal-title":"Journal of Racial and Ethnic Health Disparities"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:52:55Z","timestamp":1757433175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":38,"alternative-id":["S2949875923003235"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209271","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209271"}}